Our next-generation DLS and SLS technology enables unprecedented precision in the characterization of complex and highly scattering systems, such as highly concentrated protein solutions for injectability studies, nanocarriers like lipid nanoparticles (LNPs) and AAVs.

Cooperation possibilities

We are constantly looking for cooperations in the context of application or product development, especially in the areas of formulation development of liquid pharmaceuticals.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2010
  • Number of employees in Switzerland
    10-19

You may also be interested in